Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant ESAT6-CFP10 Allergen in Healthy Volunteers and Pulmonary Tuberculosis Patients
CTR20140196Phase 2Completed
- Sponsor
- Anhui Zhifei Longcom Biopharmaceutical
- Start
- May 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of C-Tb in Tuberculosis (TB), pulmonary tuberculosis (TB), sponsored by Anhui Zhifei Longcom Biopharmaceutical. Started May 2014; status: completed.
02
Drugs
C-Tb
03
Conditions
Tuberculosis (TB)pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on CTR20140196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140196.